137 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
- 4–6 weeks Alternatives ... day) > 1 year Alternatives ... #cryptococcus #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
malabsorption Alternative ... times weekly (AI) Alternative ... a second line alternative ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
DS PO daily Alternative ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
anti-diarrheal agent Alternative ... replacement, or alternatively ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
daily (AI), or Alternative ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
diarrhea as an alternative ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
for 30–60 days Alternative ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
1 dose (AII) Alternative ... 3 doses (AII) Alternative ... opportunistic #infections #HIVAIDS
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
and Analgesia Alternative ... #pharmacology #alternatives
Alternative or ContingencyCountermeasures for Acetylcholinesterase Inhibiting Agents
A nerve agent event may deplete local stocks of @US_FDA-approved
Alternative or ContingencyCountermeasures ... consideration of alternative ... Management #Toxicology #Alternatives